1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : SPECIALTY PHARMACEUTICALS
  4. CIDARA THERAPEUTICS INC

Cidara Therapeutics Inc

XNAS: CDTX

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Cidara Therapeutics Inc is on 08 May 2026 for the purpose of Cidara Therapeutics Inc First Quarter Earnings Results for 2026 See details


Insider Trading disclosures for Cidara Therapeutics Inc

The latest disclosure was made by Daniel D. Burgess in Cidara Therapeutics Inc where a trade of 11,100 Stock Option (right to buy) done was reported to US exchanges on Jan. 7, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Daniel D. Burgess Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 11,100 0 - - Stock Option (right to buy)
Daniel D. Burgess Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 875 0 - - Stock Option (right to buy)
Daniel D. Burgess Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 875 0 - - Stock Option (right to buy)
Daniel D. Burgess Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 550 0 - - Stock Option (right to buy)
Daniel D. Burgess Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 550 0 - - Stock Option (right to buy)
Daniel D. Burgess Director Sale or transfer of securities back to the company at price $ 221.50 per share. 07 Jan 2026 150 0 (0%) 0% 221.5 33,225 Common Stock
Daniel D. Burgess Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 450 0 - - Stock Option (right to buy)
Daniel D. Burgess Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 550 0 - - Stock Option (right to buy)
Daniel D. Burgess Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 1,400 0 - - Stock Option (right to buy)
Daniel D. Burgess Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 2,125 0 - - Stock Option (right to buy)
Daniel D. Burgess Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 2,125 0 - - Stock Option (right to buy)
Daniel D. Burgess Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 20,500 0 - - Stock Option (right to buy)
Frank L. Karbe Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 115,000 0 - - Employee Stock Option (right to buy)
Frank L. Karbe Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 43,125 0 (0%) 0% - Common Stock
Frank L. Karbe Chief Financial Officer Sale or transfer of securities back to the company at price $ 221.50 per share. 07 Jan 2026 7,526 43,125 (0%) 0% 221.5 1,667,009 Common Stock
Theodore R. Schroeder Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 2,125 0 - - Stock Option (right to buy)
Theodore R. Schroeder Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 2,125 0 - - Stock Option (right to buy)
Theodore R. Schroeder Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 20,500 0 - - Stock Option (right to buy)
Theodore R. Schroeder Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 11,100 0 - - Stock Option (right to buy)
Theodore R. Schroeder Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 550 0 - - Stock Option (right to buy)
Theodore R. Schroeder Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 550 0 - - Stock Option (right to buy)
Theodore R. Schroeder Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 550 0 - - Stock Option (right to buy)
Theodore R. Schroeder Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 450 0 - - Stock Option (right to buy)
Theodore R. Schroeder Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 875 0 - - Stock Option (right to buy)
Theodore R. Schroeder Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 875 0 - - Stock Option (right to buy)
Theodore R. Schroeder Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 1,400 0 - - Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 275,000 0 - - Employee Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Sale or transfer of securities back to the company at price $ 221.50 per share. 07 Jan 2026 67,498 0 (0%) 0% 221.5 14,950,807 Common Stock
Jeffrey Stein Director, President & CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 7,949 0 - - Employee Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 11,000 0 - - Employee Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 11,749 0 - - Employee Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 13,249 0 - - Employee Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 16,499 0 - - Employee Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 26,249 0 - - Employee Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 16,499 0 - - Employee Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 27,174 0 - - Employee Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 51,999 0 - - Employee Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 560,888 0 - - Employee Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Sale or transfer of securities back to the company at price $ 221.50 per share. 07 Jan 2026 5,763 0 (0%) 0% 221.5 1,276,505 Common Stock
Jeffrey Stein Director, President & CEO Sale or transfer of securities back to the company at price $ 221.50 per share. 07 Jan 2026 2,379 0 (0%) 0% 221.5 526,949 Common Stock
Chrysa Mineo Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 2,125 0 - - Stock Option (right to buy)
Chrysa Mineo Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 2,125 0 - - Stock Option (right to buy)
Chrysa Mineo Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 1,400 0 - - Stock Option (right to buy)
Chrysa Mineo Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 875 0 - - Stock Option (right to buy)
Chrysa Mineo Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 875 0 - - Stock Option (right to buy)
Chrysa Mineo Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 550 0 - - Stock Option (right to buy)
Chrysa Mineo Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 550 0 - - Stock Option (right to buy)
Chrysa Mineo Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 1,000 0 - - Stock Option (right to buy)
Chrysa Mineo Director Sale or transfer of securities back to the company at price $ 221.50 per share. 07 Jan 2026 3,320 0 (0%) 0% 221.5 735,380 Common Stock
Chrysa Mineo Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 11,100 0 - - Stock Option (right to buy)
Chrysa Mineo Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 19,000 0 - - Stock Option (right to buy)
Bonnie L. Bassler Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 11,100 0 - - Stock Option (right to buy)
Bonnie L. Bassler Director Sale or transfer of securities back to the company at price $ 221.53 per share. 07 Jan 2026 15 0 (0%) 0% 221.5 3,323 Common Stock
Bonnie L. Bassler Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 1,750 0 - - Stock Option (right to buy)
Bonnie L. Bassler Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 875 0 - - Stock Option (right to buy)
Bonnie L. Bassler Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 1,400 0 - - Stock Option (right to buy)
Bonnie L. Bassler Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 2,125 0 - - Stock Option (right to buy)
Bonnie L. Bassler Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 2,125 0 - - Stock Option (right to buy)
Bonnie L. Bassler Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 16,000 0 - - Stock Option (right to buy)
Shane M. Ward COO & CLO Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 12,499 0 - - Employee Stock Option (right to buy)
Shane M. Ward COO & CLO Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 135,540 0 - - Employee Stock Option (right to buy)
Shane M. Ward COO & CLO Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 50,000 0 - - Employee Stock Option (right to buy)
Shane M. Ward COO & CLO Sale or transfer of securities back to the company at price $ 221.50 per share. 07 Jan 2026 25,083 0 (0%) 0% 221.5 5,555,885 Common Stock
Shane M. Ward COO & CLO Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 12,500 0 - - Employee Stock Option (right to buy)
Shane M. Ward COO & CLO Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 6,207 0 - - Employee Stock Option (right to buy)
Ryan Spencer Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 4,250 0 - - Stock Option (right to buy)
Ryan Spencer Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 11,100 0 - - Stock Option (right to buy)
Ryan Spencer Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 2,125 0 - - Stock Option (right to buy)
Carin Canale-Theakston Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 875 0 - - Stock Option (right to buy)
Carin Canale-Theakston Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 1,750 0 - - Stock Option (right to buy)
Carin Canale-Theakston Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 11,100 0 - - Stock Option (right to buy)
Carin Canale-Theakston Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 2,125 0 - - Stock Option (right to buy)
Carin Canale-Theakston Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 16,000 0 - - Stock Option (right to buy)
Carin Canale-Theakston Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 2,125 0 - - Stock Option (right to buy)
Carin Canale-Theakston Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 1,400 0 - - Stock Option (right to buy)
James Merson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 11,100 0 - - Stock Option (right to buy)
James Merson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 2,125 0 - - Stock Option (right to buy)
James Merson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 4,250 0 - - Stock Option (right to buy)
Nicole Negar Davarpanah Chief Medical Officer Sale or transfer of securities back to the company at price $ 221.50 per share. 07 Jan 2026 12,553 8,333 (0%) 0% 221.5 2,780,490 Common Stock
Nicole Negar Davarpanah Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 8,333 0 (0%) 0% - Common Stock
Nicole Negar Davarpanah Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 11,000 0 - - Employee Stock Option (right to buy)
Nicole Negar Davarpanah Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 5,000 0 - - Employee Stock Option (right to buy)
Nicole Negar Davarpanah Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 62,597 0 - - Employee Stock Option (right to buy)
Nicole Negar Davarpanah Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 30,000 0 - - Employee Stock Option (right to buy)
Nicole Negar Davarpanah Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Jan 2026 20,000 0 - - Employee Stock Option (right to buy)
Nicole Negar Davarpanah Chief Medical Officer Gift of securities by or to the insider at price $ 0.00 per share. 29 Dec 2025 450 20,886 (0%) 0% 0 Common Stock
Frank L. Karbe Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.60 per share. 10 Dec 2025 7,290 50,562 (0%) 0% 219.6 1,600,884 Common Stock
Jeffrey Stein Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.60 per share. 10 Dec 2025 2,285 56,199 (0%) 0% 219.6 501,786 Common Stock
Shane M. Ward COO & CLO Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.60 per share. 10 Dec 2025 15,041 24,633 (0%) 0% 219.6 3,303,004 Common Stock
Shane M. Ward COO & CLO Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.20 per share. 10 Dec 2025 6,459 34,592 (0%) 0% 20.2 130,472 Common Stock
Shane M. Ward COO & CLO Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.65 per share. 10 Dec 2025 3,500 28,133 (0%) 0% 16.7 58,289 Common Stock
Shane M. Ward COO & CLO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2025 6,459 6,207 - - Employee Stock Option (right to buy)
Shane M. Ward COO & CLO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2025 3,500 0 - - Employee Stock Option (right to buy)
Shane M. Ward COO & CLO Sale of securities on an exchange or to another person at price $ 220.08 per share. 10 Dec 2025 9,959 25,033 (0%) 0% 220.1 2,191,747 Common Stock
Nicole Negar Davarpanah Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.60 per share. 10 Dec 2025 10,332 21,286 (0%) 0% 219.6 2,268,907 Common Stock
Jeffrey Stein Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 10 Dec 2025 5,425 65,109 (0%) 0% 0 Common Stock
Jeffrey Stein Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 10 Dec 2025 10,638 70,534 (0%) 0% 0 Common Stock
Jeffrey Stein Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 10 Dec 2025 10,638 10,295 (0%) 0% 0 Common Stock
Jeffrey Stein Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 10 Dec 2025 2,244 59,896 (0%) 0% 0 Common Stock
Jeffrey Stein Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 10 Dec 2025 2,244 20,883 (0%) 0% 0 Common Stock
Jeffrey Stein Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 10 Dec 2025 33,072 57,652 (0%) 0% 0 Common Stock
Jeffrey Stein Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 10 Dec 2025 33,072 23,127 (0%) 0% 0 Common Stock
Nicole Davarpanah Negar Chief Medical Officer Sale of securities on an exchange or to another person at price $ 62.86 per share. 11 Sep 2025 474 31,418 (0%) 0% 62.9 29,797 Common Stock
Daniel D. Burgess Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 11,100 11,100 - - Stock Option (right to buy)
Theodore R. Schroeder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 11,100 11,100 - - Stock Option (right to buy)
Chrysa Mineo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 11,100 11,100 - - Stock Option (right to buy)
Bonnie L. Bassler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 11,100 11,100 - - Stock Option (right to buy)
Ryan Spencer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 11,100 11,100 - - Stock Option (right to buy)
Carin Canale-Theakston Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 11,100 11,100 - - Stock Option (right to buy)
James Merson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 11,100 11,100 - - Stock Option (right to buy)
Chrysa Mineo Director Purchase of securities on an exchange or from another person at price $ 21.71 per share. 02 Jun 2025 2,270 2,270 (0%) 0% 21.7 49,281 Common Stock
Chrysa Mineo Director Purchase of securities on an exchange or from another person at price $ 23.44 per share. 02 Jun 2025 1,050 3,320 (0%) 0% 23.4 24,614 Common Stock
Nicole Negar Davarpanah Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2025 20,000 20,000 - - Employee Stock Option (right to buy)
Nicole Negar Davarpanah Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2025 10,000 31,692 (0%) 0% 0 Common Stock
Jeffrey Stein Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 275,000 275,000 - - Employee Stock Option (right to buy)
Shane M. Ward COO & CLO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 50,000 50,000 - - Employee Stock Option (right to buy)
Shane M. Ward COO & CLO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 25,000 39,674 (0%) 0% 0 Common Stock
Shane M. Ward COO & CLO Sale of securities on an exchange or to another person at price $ 21.96 per share. 11 Mar 2025 1,664 14,674 (0%) 0% 22.0 36,542 Common Stock
Leslie Tari CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 21.96 per share. 11 Mar 2025 1,773 16,215 (0%) 0% 22.0 38,940 Common Stock
Frank L. Karbe Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2025 57,500 57,500 (0%) 0% 0 Common Stock
Frank L. Karbe Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2025 115,000 115,000 - - Employee Stock Option (right to buy)
Burgess D. Daniel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2024 20,500 20,500 - - Stock Option (right to buy)
Bonnie L. Bassler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2024 16,000 16,000 - - Stock Option (right to buy)
Chrysa Mineo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2024 19,000 19,000 - - Stock Option (right to buy)
Schroeder R. Theodore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2024 20,500 20,500 - - Stock Option (right to buy)
Canale-Theakston Carin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2024 16,000 16,000 - - Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 560,888 560,888 - - Employee Stock Option (right to buy)
Shane M. Ward COO & CLO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 135,540 135,540 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 166,836 166,836 - - Employee Stock Option (right to buy)
Preetam Shah Chief Financial Officer 30 Sep 2024 130,087 130,087 - - Employee Stock Option (right to buy)
Leslie Tari CHIEF SCIENTIFIC OFFICER 30 Sep 2024 150,224 150,224 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Sale of securities on an exchange or to another person at price $ 11.64 per share. 11 Sep 2024 924 23,067 (0%) 0% 11.6 10,752 Common Stock
Leslie Tari CHIEF SCIENTIFIC OFFICER 11 Sep 2024 909 17,788 (0%) 0% 11.6 10,580 Common Stock
Daniel D. Burgess Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jul 2024 2,125 2,125 - - Stock Option (right to buy)
Theodore R. Schroeder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jul 2024 2,125 2,125 - - Stock Option (right to buy)
Chrysa Mineo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jul 2024 2,125 2,125 - - Stock Option (right to buy)
Bonnie L. Bassler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jul 2024 2,125 2,125 - - Stock Option (right to buy)
Ryan Spencer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jul 2024 2,125 2,125 - - Stock Option (right to buy)
Carin Canale-Theakston Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jul 2024 2,125 2,125 - - Stock Option (right to buy)
James Merson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jul 2024 2,125 2,125 - - Stock Option (right to buy)
Laura Tadvalkar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jul 2024 2,125 2,125 - - Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 13.21 per share. 07 Jun 2024 8,000 24,580 (0%) 0% 13.2 105,680 Common Stock
Ryan Spencer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2024 4,250 4,250 - - Stock Option (right to buy)
James Merson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2024 4,250 4,250 - - Stock Option (right to buy)
Laura Tadvalkar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2024 4,250 4,250 - - Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 1,040,000 1,040,000 - - Employee Stock Option (right to buy)
Shane M. Ward COO & CLO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 120,000 318,770 (0%) 0% 0 Common Stock
Shane M. Ward COO & CLO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 250,000 250,000 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 235,500 235,500 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 128,750 475,845 (1%) 0% 0 Common Stock
Preetam Shah CFO & CBO 15 Mar 2024 217,500 217,500 - - Employee Stock Option (right to buy)
Preetam Shah CFO & CBO 15 Mar 2024 108,750 335,960 (0%) 0% 0 Common Stock
Leslie Tari CHIEF SCIENTIFIC OFFICER 15 Mar 2024 222,500 222,500 - - Employee Stock Option (right to buy)
Leslie Tari CHIEF SCIENTIFIC OFFICER 15 Mar 2024 111,250 369,931 (0%) 0% 0 Common Stock
Jeffrey Stein Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.69 per share. 11 Mar 2024 56,692 1,153,693 (2%) 0% 0.7 39,117 Common Stock
Shane M. Ward COO & CLO Sale of securities on an exchange or to another person at price $ 0.67 per share. 11 Mar 2024 20,473 198,770 (0%) 0% 0.7 13,713 Common Stock
Taylor Sandison Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.67 per share. 11 Mar 2024 20,662 347,095 (0%) 0% 0.7 13,839 Common Stock
Preetam Shah CFO & CBO 11 Mar 2024 18,931 227,210 (0%) 0% 0.7 12,680 Common Stock
Leslie Tari CHIEF SCIENTIFIC OFFICER 11 Mar 2024 21,029 258,681 (0%) 0% 0.7 14,085 Common Stock
Leslie Tari CHIEF SCIENTIFIC OFFICER 14 Aug 2023 10,000 294,179 (0%) 0% 1.0 9,700 Common Stock
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.96 per share. 08 Aug 2023 50,000 331,602 (0%) 0% 1.0 47,885 Common Stock
Daniel D. Burgess Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 42,500 42,500 - - Stock Option (right to buy)
Theodore R. Schroeder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 42,500 42,500 - - Stock Option (right to buy)
Timothy R. Franson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 42,500 42,500 - - Stock Option (right to buy)
Chrysa Mineo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 42,500 42,500 - - Stock Option (right to buy)
Bonnie L. Bassler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 42,500 42,500 - - Stock Option (right to buy)
David L. Gollaher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 42,500 42,500 - - Stock Option (right to buy)
Carin Canale-Theakston Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 42,500 42,500 - - Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Mar 2023 543,500 543,500 - - Employee Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 1.04 per share. 27 Mar 2023 50,000 281,602 (0%) 0% 1.0 51,855 Common Stock
Jeffrey Stein Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Mar 2023 271,750 1,202,385 (2%) 0% 0 Common Stock
Shane M. Ward COO & CLO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Mar 2023 126,667 211,243 (0%) 0% 0 Common Stock
Shane M. Ward COO & CLO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Mar 2023 253,333 253,333 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Mar 2023 90,000 378,550 (0%) 0% 0 Common Stock
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Mar 2023 180,000 180,000 - - Employee Stock Option (right to buy)
Preetam Shah CFO & CBO 27 Mar 2023 90,000 238,141 (0%) 0% 0 Common Stock
Preetam Shah CFO & CBO 27 Mar 2023 180,000 180,000 - - Employee Stock Option (right to buy)
Leslie Tari CHIEF SCIENTIFIC OFFICER 27 Mar 2023 90,000 280,179 (0%) 0% 0 Common Stock
Leslie Tari CHIEF SCIENTIFIC OFFICER 27 Mar 2023 180,000 180,000 - - Employee Stock Option (right to buy)
Shane M. Ward COO & CLO Sale of securities on an exchange or to another person at price $ 1.53 per share. 13 Mar 2023 4,329 84,576 (0%) 0% 1.5 6,623 Common Stock
Taylor Sandison Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.53 per share. 13 Mar 2023 7,203 288,550 (0%) 0% 1.5 11,021 Common Stock
Preetam Shah CFO & CBO 13 Mar 2023 6,648 148,141 (0%) 0% 1.5 10,171 Common Stock
Leslie Tari CHIEF SCIENTIFIC OFFICER 13 Mar 2023 7,562 190,179 (0%) 0% 1.5 11,570 Common Stock
Leslie Tari CHIEF SCIENTIFIC OFFICER 12 Jan 2023 11,814 1,484 (0%) 0% 1.2 14,177 Common Stock
Preetam Shah CFO & CBO 15 Sep 2022 50,000 0 - - Restricted Stock Unit
Preetam Shah CFO & CBO 15 Sep 2022 15,642 150,789 (0%) 0% 0.8 12,035 Common Stock
Preetam Shah CFO & CBO 15 Sep 2022 50,000 166,431 (0%) 0% 0 Common Stock
Paul Daruwala Chief Operating Officer Sale of securities on an exchange or to another person at price $ 0.68 per share. 12 Sep 2022 16,199 221,099 (0%) 0% 0.7 11,095 Common Stock
Taylor Sandison Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.68 per share. 12 Sep 2022 18,478 291,753 (0%) 0% 0.7 12,656 Common Stock
Leslie Tari CHIEF SCIENTIFIC OFFICER 12 Sep 2022 18,159 193,741 (0%) 0% 0.7 12,437 Common Stock
Daniel D. Burgess Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 28,000 28,000 - - Stock Option (right to buy)
Theodore R. Schroeder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 28,000 28,000 - - Stock Option (right to buy)
Timothy R. Franson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 28,000 28,000 - - Stock Option (right to buy)
Chrysa Mineo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 28,000 28,000 - - Stock Option (right to buy)
Bonnie L. Bassler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 28,000 28,000 - - Stock Option (right to buy)
David L. Gollaher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 28,000 28,000 - - Stock Option (right to buy)
Carin Canale-Theakston Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 28,000 28,000 - - Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.83 per share. 31 Mar 2022 140,985 922,635 (2%) 0% 0.8 117,018 Common Stock
Jeffrey Stein Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 330,000 330,000 - - Employee Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 408,742 1,063,620 (2%) 1% 0 Common Stock
Jeffrey Stein Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 165,000 654,878 (1%) 0% 0 Common Stock
Shane M. Ward CHIEF LEGAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 69,027 104,027 (0%) 0% 0 Common Stock
Shane M. Ward CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.83 per share. 31 Mar 2022 23,122 80,905 (0%) 0% 0.8 19,191 Common Stock
Shane M. Ward CHIEF LEGAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 35,000 35,000 (0%) 0% 0 Common Stock
Shane M. Ward CHIEF LEGAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 70,000 70,000 - - Employee Stock Option (right to buy)
Paul Daruwala Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 100,000 100,000 - - Employee Stock Option (right to buy)
Paul Daruwala Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 50,000 237,298 (0%) 0% 0 Common Stock
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 50,000 306,231 (0%) 0% 0 Common Stock
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 100,000 100,000 - - Employee Stock Option (right to buy)
Brady Johnson Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 20,000 20,000 - - Employee Stock Option (right to buy)
Brady Johnson Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 10,000 59,366 (0%) 0% 0 Common Stock
Preetam Shah CFO & CBO 31 Mar 2022 66,001 137,251 (0%) 0% 0 Common Stock
Preetam Shah CFO & CBO 31 Mar 2022 51,250 71,250 (0%) 0% 0 Common Stock
Preetam Shah CFO & CBO 31 Mar 2022 24,820 112,431 (0%) 0% 0.8 20,601 Common Stock
Preetam Shah CFO & CBO 31 Mar 2022 102,500 102,500 - - Employee Stock Option (right to buy)
Leslie Tari CHIEF SCIENTIFIC OFFICER 31 Mar 2022 105,000 105,000 - - Employee Stock Option (right to buy)
Leslie Tari CHIEF SCIENTIFIC OFFICER 31 Mar 2022 52,500 207,900 (0%) 0% 0 Common Stock
Brady Johnson Vice President, Finance Sale of securities on an exchange or to another person at price $ 0.81 per share. 21 Mar 2022 654 49,366 (0%) 0% 0.8 530 Common Stock
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 1.59 per share. 12 Nov 2021 50,000 465,878 (1%) 0% 1.6 79,530 Common Stock
Preetam Shah CFO & CBO 12 Nov 2021 20,000 20,000 (0%) 0% 1.5 30,800 Common Stock
Paul Daruwala Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 132,000 182,531 (0%) 0% 0 Common Stock
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 150,600 236,631 (0%) 0% 0 Common Stock
Brady Johnson Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 20,750 47,119 (0%) 0% 0 Common Stock
Leslie Tari CHIEF SCIENTIFIC OFFICER 30 Sep 2021 148,000 150,551 (0%) 0% 0 Common Stock
Timothy R. Franson Director Purchase of securities on an exchange or from another person at price $ 2.12 per share. 13 Sep 2021 7,000 11,000 (0%) 0% 2.1 14,823 Common Stock
Preetam Shah CFO & CBO 01 Sep 2021 50,000 50,000 - - Restricted Stock Unit
Preetam Shah CFO & CBO 01 Sep 2021 311,850 311,850 - - Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 1.79 per share. 18 Aug 2021 10,000 415,878 (1%) 0% 1.8 17,871 Common Stock
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 1.72 per share. 18 Aug 2021 40,000 405,878 (1%) 0% 1.7 68,884 Common Stock
Daniel D. Burgess Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 17,500 17,500 - - Stock Option (right to buy)
Theodore R. Schroeder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 17,500 17,500 - - Stock Option (right to buy)
Timothy R. Franson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 17,500 17,500 - - Stock Option (right to buy)
Chrysa Mineo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 17,500 17,500 - - Stock Option (right to buy)
Bonnie L. Bassler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 17,500 17,500 - - Stock Option (right to buy)
David L. Gollaher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 17,500 17,500 - - Stock Option (right to buy)
Carin Canale-Theakston Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 17,500 17,500 - - Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2021 10,000 361,878 (0%) 0% 0 Common Stock
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2021 700 82,031 (0%) 0% 0 Common Stock
James E. Levine Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2021 130,000 130,000 - - Employee Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2021 525,000 525,000 - - Employee Stock Option (right to buy)
Paul Daruwala Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2021 120,000 120,000 - - Employee Stock Option (right to buy)
Neil Abdollahian Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2021 150,000 150,000 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2021 145,000 145,000 - - Employee Stock Option (right to buy)
Jessica Oien General Counsel & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2021 135,000 135,000 - - Employee Stock Option (right to buy)
Bonnie L. Bassler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2021 35,000 35,000 - - Stock Option (right to buy)
Carin Canale-Theakston Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2021 35,000 35,000 - - Stock Option (right to buy)
Paul Daruwala Chief Operating Officer Sale of securities on an exchange or to another person at price $ 2.06 per share. 05 Jan 2021 2,868 49,724 (0%) 0% 2.1 5,908 Common Stock
Paul Daruwala Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2021 1,400 51,124 (0%) 0% 0 Common Stock
Paul Daruwala Chief Operating Officer Sale of securities on an exchange or to another person at price $ 2.66 per share. 05 Jan 2021 593 50,531 (0%) 0% 2.7 1,577 Common Stock
Neil Abdollahian Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2021 3,500 58,940 (0%) 0% 0 Common Stock
Neil Abdollahian Chief Business Officer Sale of securities on an exchange or to another person at price $ 2.06 per share. 05 Jan 2021 2,868 55,440 (0%) 0% 2.1 5,908 Common Stock
Neil Abdollahian Chief Business Officer Sale of securities on an exchange or to another person at price $ 2.66 per share. 05 Jan 2021 1,469 57,471 (0%) 0% 2.7 3,908 Common Stock
Jessica Oien General Counsel & Secretary Sale of securities on an exchange or to another person at price $ 2.06 per share. 05 Jan 2021 824 6,141 (0%) 0% 2.1 1,697 Common Stock
Jessica Oien General Counsel & Secretary Sale of securities on an exchange or to another person at price $ 2.66 per share. 05 Jan 2021 1,177 7,764 (0%) 0% 2.7 3,131 Common Stock
Jessica Oien General Counsel & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2021 2,800 8,941 (0%) 0% 0 Common Stock
James E. Levine Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 2.01 per share. 10 Nov 2020 50,000 50,000 (0%) 0% 2.0 100,720 Common Stock
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 2.00 per share. 10 Nov 2020 50,000 347,878 (0%) 0% 2.0 100,015 Common Stock
Daniel D. Burgess Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 17,500 17,500 - - Stock Option (right to buy)
Theodore R. Schroeder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 17,500 17,500 - - Stock Option (right to buy)
Timothy R. Franson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 17,500 17,500 - - Stock Option (right to buy)
Chrysa Mineo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 17,500 17,500 - - Stock Option (right to buy)
David L. Gollaher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 17,500 17,500 - - Stock Option (right to buy)
James E. Levine Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Mar 2020 110,000 110,000 - - Employee Stock Option (right to buy)
James E. Levine Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2020 25,000 61,891 (0%) 0% 0 Common Stock
Jeffrey Stein Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2020 330,000 330,000 - - Employee Stock Option (right to buy)
Paul Daruwala Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2020 90,000 90,000 - - Employee Stock Option (right to buy)
Neil Abdollahian Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2020 115,000 115,000 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2020 145,000 145,000 - - Employee Stock Option (right to buy)
Jessica Oien General Counsel & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2020 90,000 90,000 - - Employee Stock Option (right to buy)
Jeffrey Stein Director, President & CEO 29 Jan 2020 32,283 257,902 (0%) 0% 2.5 81,030 Common Stock
Jeffrey Stein Director, President & CEO 29 Jan 2020 32,283 0 - - Subscription Rights (right to buy)
Jeffrey Stein Director, President & CEO 29 Jan 2020 7,558 0 - - Subscription Rights (right to buy)
Jeffrey Stein Director, President & CEO 29 Jan 2020 7,558 293,878 (0%) 0% 2.5 18,971 Common Stock
James E. Levine Chief Financial Officer 28 Jan 2020 6,891 0 - - Subscription Rights (right to buy)
James E. Levine Chief Financial Officer 28 Jan 2020 6,891 211,891 (0%) 0% 2.5 17,296 Common Stock
Paul Daruwala Chief Operating Officer Sale of securities on an exchange or to another person at price $ 3.42 per share. 03 Jan 2020 940 52,592 (0%) 0% 3.4 3,215 Common Stock
Neil Abdollahian Chief Business Officer Sale of securities on an exchange or to another person at price $ 3.42 per share. 03 Jan 2020 940 50,308 (0%) 0% 3.4 3,215 Common Stock
Jessica Oien General Counsel & Secretary Sale of securities on an exchange or to another person at price $ 3.86 per share. 02 Jan 2020 834 6,965 (0%) 0% 3.9 3,219 Common Stock
Paul Daruwala Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 33,333 33,333 - - Employee Stock Option (right to buy)
Paul Daruwala Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 17,125 17,125 - - Employee Stock Option (right to buy)
Paul Daruwala Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Dec 2019 50,000 0 - - Employee Stock Option (right to buy)
Paul Daruwala Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Dec 2019 25,688 0 - - Employee Stock Option (right to buy)
Paul Daruwala Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 4,074 4,074 - - Employee Stock Option (right to buy)
Paul Daruwala Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 32,592 32,592 - - Employee Stock Option (right to buy)
Paul Daruwala Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Dec 2019 55,000 0 - - Employee Stock Option (right to buy)
Neil Abdollahian Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 29,629 29,629 - - Employee Stock Option (right to buy)
Neil Abdollahian Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 9,721 9,721 - - Employee Stock Option (right to buy)
Neil Abdollahian Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 56,945 56,945 - - Employee Stock Option (right to buy)
Neil Abdollahian Chief Business Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Dec 2019 100,000 0 - - Employee Stock Option (right to buy)
Neil Abdollahian Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 3,704 3,704 - - Employee Stock Option (right to buy)
Neil Abdollahian Chief Business Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Dec 2019 50,000 0 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 4,075 4,075 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Dec 2019 55,000 0 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 13,333 13,333 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Dec 2019 20,000 0 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 3,333 3,333 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Dec 2019 5,000 0 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 12,667 12,667 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Dec 2019 19,000 0 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 32,592 32,592 - - Employee Stock Option (right to buy)
Paul Daruwala Chief Operating Officer Sale of securities on an exchange or to another person at price $ 1.88 per share. 02 Oct 2019 3,295 55,872 (0%) 0% 1.9 6,195 Common Stock
Neil Abdollahian Chief Business Officer Sale of securities on an exchange or to another person at price $ 1.98 per share. 01 Oct 2019 7,284 49,588 (0%) 0% 2.0 14,422 Common Stock
Jessica Oien General Counsel & Secretary Sale of securities on an exchange or to another person at price $ 1.86 per share. 27 Sep 2019 1,001 7,799 (0%) 0% 1.9 1,862 Common Stock
James E. Levine Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.91 per share. 24 Sep 2019 30,000 30,000 (0%) 0% 1.9 57,240 Common Stock
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 1.91 per share. 24 Sep 2019 52,500 225,619 (0%) 0% 1.9 100,102 Common Stock
Jeffrey Stein Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Sep 2019 10,000 50,000 - - Restricted Stock Unit
Jeffrey Stein Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2019 10,000 282,320 (0%) 0% 0 Common Stock
Paul Daruwala Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Sep 2019 2,100 11,900 - - Restricted Stock Unit
Paul Daruwala Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2019 7,500 57,067 (0%) 0% 0 Common Stock
Paul Daruwala Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2019 2,100 59,167 (0%) 0% 0 Common Stock
Paul Daruwala Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Sep 2019 7,500 17,500 - - Restricted Stock Unit
Neil Abdollahian Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2019 4,900 56,872 (0%) 0% 0 Common Stock
Neil Abdollahian Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2019 17,500 51,972 (0%) 0% 0 Common Stock
Neil Abdollahian Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Sep 2019 4,900 9,100 - - Restricted Stock Unit
Neil Abdollahian Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Sep 2019 17,500 7,500 - - Restricted Stock Unit
Taylor Sandison Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Sep 2019 2,500 22,500 - - Restricted Stock Unit
Taylor Sandison Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Sep 2019 1,400 12,600 - - Restricted Stock Unit
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2019 1,400 58,622 (0%) 0% 0 Common Stock
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2019 2,500 57,222 (0%) 0% 0 Common Stock
Jessica Oien General Counsel & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2019 2,800 8,800 (0%) 0% 0 Common Stock
Jessica Oien General Counsel & Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Sep 2019 2,800 11,200 - - Restricted Stock Unit
Daniel D. Burgess Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 11,000 11,000 - - Stock Option (right to buy)
Theodore R. Schroeder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 11,000 11,000 - - Stock Option (right to buy)
Timothy R. Franson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 11,000 11,000 - - Stock Option (right to buy)
Chrysa Mineo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 11,000 11,000 - - Stock Option (right to buy)
David L. Gollaher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 11,000 11,000 - - Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2019 265,000 265,000 - - Employee Stock Option (right to buy)
Paul Daruwala Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2019 77,000 77,000 - - Employee Stock Option (right to buy)
Neil Abdollahian Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2019 77,000 77,000 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2019 65,000 65,000 - - Employee Stock Option (right to buy)
Jessica Oien General Counsel & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2019 65,000 65,000 - - Employee Stock Option (right to buy)
Neil Abdollahian Chief Business Officer Sale of securities on an exchange or to another person at price $ 2.44 per share. 08 Mar 2019 2,300 30,472 (0%) 0% 2.4 5,612 Common Stock
Paul Daruwala Chief Operating Officer Sale of securities on an exchange or to another person at price $ 2.55 per share. 07 Mar 2019 2,240 49,567 (0%) 0% 2.6 5,714 Common Stock
Jeffrey Stein Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 26 Feb 2019 10,670 15,709 (0%) 0% 0 Common Stock
Jeffrey Stein Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 26 Feb 2019 21,340 173,119 (0%) 0% 0 Common Stock
Jeffrey Stein Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jan 2019 60,000 60,000 - - Restricted Stock Unit
Paul Daruwala Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jan 2019 14,000 14,000 - - Restricted Stock Unit
Paul Daruwala Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2019 6,000 51,807 (0%) 0% 0 Common Stock
Neil Abdollahian Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jan 2019 14,000 14,000 - - Restricted Stock Unit
Neil Abdollahian Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2019 6,000 32,772 (0%) 0% 0 Common Stock
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2019 6,000 50,722 (0%) 0% 0 Common Stock
Taylor Sandison Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jan 2019 14,000 14,000 - - Restricted Stock Unit
Jessica Oien General Counsel & Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jan 2019 14,000 14,000 - - Restricted Stock Unit
Jessica Oien General Counsel & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2019 6,000 6,000 (0%) 0% 0 Common Stock
James E. Levine Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Dec 2018 175,000 175,000 - - Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 29 Nov 2018 4,619 5,039 (0%) 0% 0 Common Stock
Jeffrey Stein Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 29 Nov 2018 9,238 194,459 (0%) 0% 0 Common Stock
Brady Johnson Dir. of Finance & Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Sep 2018 4,000 4,000 - - Stock Option (Right to Buy)
David L. Gollaher None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Sep 2018 20,000 20,000 - - Stock Option (right to buy)
Daniel D. Burgess None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2018 11,000 11,000 - - Stock Option (right to buy)
Scott M. Rocklage None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2018 11,000 11,000 - - Stock Option (right to buy)
Theodore R. Schroeder None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2018 11,000 11,000 - - Stock Option (right to buy)
Timothy R. Franson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2018 11,000 11,000 - - Stock Option (right to buy)
Chrysa Mineo None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2018 11,000 11,000 - - Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 250,000 250,000 - - Warrant (right to buy)
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 4.70 per share. 23 May 2018 212,766 268,320 (1%) 0% 4.7 1,000,000 Common Stock
Matthew W. Onaitis Gnrl Counsel, CFO & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2018 72,000 72,000 - - Employee Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2018 235,000 235,000 - - Employee Stock Option (right to buy)
Paul Daruwala Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2018 72,000 72,000 - - Employee Stock Option (right to buy)
Neil Abdollahian Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2018 70,000 70,000 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2018 70,000 70,000 - - Employee Stock Option (right to buy)
Chrysa Mineo None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2018 20,000 20,000 - - Stock Option (right to buy)
Matthew W. Onaitis Gnrl Counsel, CFO & Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Sep 2017 25,000 25,000 - - Restricted Stock Unit
Matthew W. Onaitis Gnrl Counsel, CFO & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2017 15,000 15,872 (0%) 0% 0 Common Stock
Paul Daruwala Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2017 15,000 45,807 (0%) 0% 0 Common Stock
Paul Daruwala Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Sep 2017 25,000 25,000 - - Restricted Stock Unit
Marc J.S. Wilson Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2017 5,000 10,356 (0%) 0% 0 Common Stock
Marc J.S. Wilson Chief Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Sep 2017 10,000 10,000 - - Restricted Stock Unit
Neil Abdollahian Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Sep 2017 25,000 25,000 - - Restricted Stock Unit
Neil Abdollahian Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2017 15,000 20,421 (0%) 0% 0 Common Stock
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2017 15,000 40,695 (0%) 0% 0 Common Stock
Taylor Sandison Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Sep 2017 25,000 25,000 - - Restricted Stock Unit
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 6.79 per share. 12 Sep 2017 7,350 51,851 (0%) 0% 6.8 49,907 Common Stock
Daniel D. Burgess None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2017 11,000 11,000 - - Stock Option (right to buy)
Robert J. Perez None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2017 11,000 11,000 - - Stock Option (right to buy)
Scott M. Rocklage Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2017 11,000 11,000 - - Stock Option (right to buy)
Theodore R. Schroeder None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2017 11,000 11,000 - - Stock Option (right to buy)
Timothy R. Franson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2017 11,000 11,000 - - Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 5.90 per share. 06 Jun 2017 19,344 25,695 (0%) 0% 5.9 114,130 Common Stock
Taylor Sandison Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 5.90 per share. 06 Jun 2017 656 6,351 (0%) 0% 5.9 3,870 Common Stock
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 5.95 per share. 05 Jun 2017 15,000 44,501 (0%) 0% 5.9 89,211 Common Stock
Matthew W. Onaitis Gnrl Counsel, CFO & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2017 55,000 55,000 - - Employee Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 7.75 per share. 31 Mar 2017 12,900 27,196 (0%) 0% 7.8 99,975 Common Stock
Jeffrey Stein Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2017 220,000 220,000 - - Employee Stock Option (right to buy)
Kenneth Bartizal Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2017 50,000 50,000 - - Employee Stock Option (right to buy)
Kevin Forrest Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 7.75 per share. 31 Mar 2017 12,500 72,354 (0%) 0% 7.8 96,875 Common Stock
Kevin Forrest Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2017 60,000 60,000 - - Employee Stock Option (right to buy)
Paul Daruwala Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2017 55,000 55,000 - - Employee Stock Option (right to buy)
Neil Abdollahian Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2017 50,000 50,000 - - Employee Stock Option (right to buy)
Taylor Sandison Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2017 55,000 55,000 - - Employee Stock Option (right to buy)
Matthew W. Onaitis Gnrl Counsel, CFO & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2016 110,000 110,000 - - Stock Option (right to buy)
Neil Abdollahian Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2016 100,000 100,000 - - Stock Option (right to buy)
Daniel D. Burgess Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2016 9,000 9,000 - - Stock Option (right to buy)
Robert J. Perez Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2016 9,000 9,000 - - Stock Option (right to buy)
Scott M. Rocklage Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2016 9,000 9,000 - - Stock Option (right to buy)
Theodore R. Schroeder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2016 9,000 9,000 - - Stock Option (right to buy)
Timothy R. Franson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2016 9,000 9,000 - - Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 40.01 per share. 23 May 2016 2,500 69,371 (0%) 0% 40.0 100,015 Common Stock
Jeffrey Stein Director, President & CEO Other type of transaction at price $ 0.00 per share. 23 May 2016 658 1,442 (0%) 0% 0 Common Stock
Jeffrey Stein Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 23 May 2016 1,873 67,498 (0%) 0% 0 Common Stock
Jeffrey Stein Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 23 May 2016 937 2,379 (0%) 0% 0 Common Stock
Jeffrey Stein Director, President & CEO Other type of transaction at price $ 0.00 per share. 23 May 2016 270 10,025 (0%) 0% - Common Stock
Jeffrey Stein Director, President & CEO Other type of transaction at price $ 155.00 per share. 23 May 2016 645 9,380 (0%) 0% 155 99,975 Common Stock
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 155.00 per share. 23 May 2016 645 65,754 (0%) 0% 155 99,975 Common Stock
Jeffrey Stein Director, President & CEO Other type of transaction at price $ 118.95 per share. 23 May 2016 750 8,630 (0%) 0% 118.9 89,211 Common Stock
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 118.95 per share. 23 May 2016 750 66,504 (0%) 0% 118.9 89,211 Common Stock
Jeffrey Stein Director, President & CEO Other type of transaction at price $ 135.80 per share. 23 May 2016 367 8,263 (0%) 0% 135.8 49,839 Common Stock
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 135.80 per share. 23 May 2016 367 66,871 (0%) 0% 135.8 49,839 Common Stock
Jeffrey Stein Director, President & CEO Other type of transaction at price $ 40.01 per share. 23 May 2016 2,500 5,763 (0%) 0% 40.0 100,015 Common Stock
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 May 2016 4,310 203,697 (0%) - - Common Stock
Kevin Forrest COO & CFO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 May 2016 4,356 58,253 (0%) - - Common Stock
Jeffrey Stein Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2016 159,000 159,000 - - Stock Option (right to buy)
Kenneth Bartizal Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2016 50,000 50,000 - - Stock Option (right to buy)
Kevin Forrest COO & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2016 65,000 65,000 - - Stock Option (right to buy)
Paul Daruwala Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2016 50,000 50,000 - - Stock Option (right to buy)
Dirk Thye Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2016 80,000 80,000 - - Stock Option (right to buy)
Marc J.S. Wilson Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2016 25,000 25,000 - - Employee Stock Option (right to buy)
Marc J.S. Wilson Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2016 12,000 12,000 - - Employee Stock Option (right to buy)
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Nov 2015 1,300 6,700 - - Common Stock
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Nov 2015 5,400 5,400 - - Common Stock
Kevin Forrest COO & CFO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Nov 2015 7,087 51,719 - - Common Stock
Daniel D. Burgess None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2015 9,000 9,000 - - Stock Option (right to buy)
Robert J. Perez None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2015 9,000 9,000 - - Stock Option (right to buy)
Scott M. Rocklage Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2015 9,000 9,000 - - Stock Option (right to buy)
Theodore R. Schroeder None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2015 9,000 9,000 - - Stock Option (right to buy)
Timothy R. Franson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2015 9,000 9,000 - - Stock Option (right to buy)
Daniel D. Burgess None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 Apr 2015 3,000 3,000 - - Common Stock
Robert J. Perez None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 Apr 2015 5,000 5,000 - - Common Stock
Scott M. Rocklage Director, Ten Percent Owner 20 Apr 2015 1,764,195 1,956,099 - - Common Stock
Scott M. Rocklage Director, Ten Percent Owner 20 Apr 2015 1,764,195 0 - - Convertible Preferred Stock
Scott M. Rocklage Director, Ten Percent Owner 20 Apr 2015 45,467 50,412 - - Common Stock
Scott M. Rocklage Director, Ten Percent Owner 20 Apr 2015 45,467 0 - - Convertible Preferred Stock
Patrick J. Heron None 20 Apr 2015 865,590 0 - - Convertible Preferred Stock
Patrick J. Heron None 20 Apr 2015 246,668 291,023 - - Common Stock
Patrick J. Heron None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 Apr 2015 44,355 44,355 - - Common Stock
Patrick J. Heron None 20 Apr 2015 246,668 0 - - Convertible Preferred Stock
Patrick J. Heron None 20 Apr 2015 865,590 1,021,235 - - Common Stock
Patrick J. Heron None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 Apr 2015 155,645 155,645 - - Common Stock
Steven A. Elms None 20 Apr 2015 8,928,572 0 - - Convertible Preferred Stock
Steven A. Elms None 20 Apr 2015 351,518 351,518 - - Common Stock
Timothy R. Franson None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 Apr 2015 4,000 4,000 - - Common Stock
Nina Kjellson None 20 Apr 2015 1,156,813 0 - - Convertible Preferred Stock
Nina Kjellson None 20 Apr 2015 1,156,813 1,356,813 - - Common Stock
Nina Kjellson None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 Apr 2015 200,000 200,000 - - Common Stock
Jeffrey Stein Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 Apr 2015 420 420 - - Common Stock
Taylor Sandison Chief Medical Officer 07 Feb 2010 4,594 67,216 (0%) 0% 2.5 11,531 Common Stock
Taylor Sandison Chief Medical Officer 07 Feb 2010 6,115 73,331 (0%) 0% 2.5 15,349 Common Stock
Taylor Sandison Chief Medical Officer 07 Feb 2010 4,594 0 - - Subscription Rights (right to buy)
Taylor Sandison Chief Medical Officer 07 Feb 2010 6,115 0 - - Subscription Rights (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters